FDA-cleared biomarker test for pediatric acute kidney injury risk assessment. Available for use on Roche Diagnostics Cobas c 501 clinical chemistry analyzer to rapidly identify kidney damage in pediatric patients.
Manufactured by
United States
ProNephro AKI (NGAL) is designed to aid in the risk assessment of acute kidney injury (AKI) in ICU patients 3 months to 22 years. A low NGAL value indicates a low risk of AKI, allowing for confident use of interventions such as fluids, diuretics, or nephrotoxic medications. Elevated NGAL values signal a high risk of developing AKI and can trigger nephrology consults and interventions 2-3 days before serum creatinine rises.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Micropoint Bioscience, Inc.
United States · 3 relevant products
Hangzhou Elit Biotech Co.,Ltd.
China · 1 relevant product
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 3 relevant products
PRIMA Lab SA
Switzerland · 2 relevant products
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 2 relevant products
Bio Preventive Medicine Co. Ltd.
Taiwan · 6 relevant products
GenSure Biotech Inc.
China · 1 relevant product
Lansion Biotechnology Co., Ltd.
China · 1 relevant product
ARGERON MEDİKAL ARAŞ.SAN.VE TİC.A.Ş.
Türkiye · 2 relevant products
Anhui Huibang Biological Engineering Co., Ltd.
China · 9 relevant products
58 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 102 closest product alternatives
Micropoint Bioscience, Inc. · United States
A point-of-care diagnostic test device for measuring neutrophil gelatinase-associated lipocalin (NGAL), a biomarker for kidney injury assessment. Based on microfluidic technology for rapid clinical testing.
Hangzhou Elit Biotech Co.,Ltd. · China
A rapid diagnostic test for the detection of Neutrophil Gelatinase-Associated Lipocalin (NGAL), a biomarker used in clinical assessment.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
A diagnostic reagent kit for detecting neutrophil gelatinase-associated lipocalin using colloidal gold immunochromatography method. This test is used for kidney injury assessment.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
A diagnostic test kit for detecting neutrophil gelatinase-associated lipocalin using colloidal gold immunochromatographic method. This kit is used for clinical laboratory testing to measure NGAL levels in patient samples.
PRIMA Lab SA · Switzerland
The first rapid test for semi-quantitative detection of NGAL in urine for early screening of kidney damage in dogs
Shenzhen Kingfocus Biomedical Engineering Co., Ltd. · China
Diagnostic assays for detection of kidney injury markers in serum and urine samples. Enables early identification and monitoring of acute and chronic renal dysfunction.
Bio Preventive Medicine Co. Ltd. · Taiwan
A non-invasive urine-based diagnostic test designed to predict rapid kidney function deterioration in chronic kidney disease patients. This biomarker assay provides quantitative risk assessment to support early clinical intervention and disease management.
GenSure Biotech Inc. · China
Diagnostic test kit for measurement of kidney function biomarkers including creatinine and urea. Facilitates assessment of renal function and detection of kidney disease.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for kidney function assessment. Provides rapid results for renal biomarker detection.
ARGERON MEDİKAL ARAŞ.SAN.VE TİC.A.Ş. · Türkiye
A diagnostic test that measures urinary trehalase enzyme activity to help identify kidney injury earlier than conventional indicators. It offers early injury signal detection via trehalase activity, is compatible with standard analyzers, and provides fast, practical and highly sensitive results supporting clinical research.
Bio Preventive Medicine Co. Ltd. · Taiwan
An in vitro diagnostic test that predicts the risk of rapid renal function decline in diabetic kidney disease patients. This urine-based biomarker test provides early risk assessment before symptomatic deterioration occurs, enabling timely clinical intervention.
PRIMA Lab SA · Switzerland
Rapid diagnostic test for albumin detection in kidney function assessment. This easy-to-use test enables quick monitoring of proteinuria and renal health status in clinical and point-of-care settings. CE-certified with customizable configurations available for laboratory integration.
90 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products